Hanall Biopharma Co., Ltd. (KRX:009420)
South Korea flag South Korea · Delayed Price · Currency is KRW
53,600
+2,800 (5.51%)
Nov 17, 2026, 3:30 PM KST

Hanall Biopharma Market Cap

Hanall Biopharma has a market cap or net worth of 2.73 trillion as of November 16, 2026. It is the 6,402nd most valuable company in the world and the 139th biggest in South Korea. Its market cap has increased by 22.84% in one year.

Market Cap
2.73T
Enterprise Value
2.74T
Revenue
162.66B
Global Rank
Country Rank
#139 South Korea
PE Ratio
n/a

Chart

Chart

Since August 30, 1995, Hanall Biopharma's market cap has increased from 26.30B to 2.73T, an increase of 10,265.29%. That is a compound annual growth rate of 16.02%.

History

DateMarket Cap% Change
Nov 17, 20262.73T22.70%
Dec 30, 20252.22T13.35%
Dec 30, 20241.96T-12.72%
Dec 28, 20232.25T148.89%
Dec 29, 2022902.29B-16.29%
Dec 30, 20211.08T-43.84%
Dec 30, 2020 Pro Pro
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding